· Form D filing · Baseline
Reported sold as filed: $612,503 · Offering amount as filed: $5,000,000
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗Immorta Bio, Inc.
On its website, the company describes its work as “Technologies Seno Vax™ Autologous Approach To Eliminate Senescent Cells More About SenoVax™ StemCell Revivify™ Rebuild Damaged Organs and Tissues With Stem Cells More About StemCellRevivify™…”.
- Industry
- Biotechnology
- Tracked VC backers
- 0
- Location
- Not recorded
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.